Abstract. Pyrogallol, a polyphenol, is known to be a superoxide anion (O 2 •-) generator. We investigated the involvement of glutathione (GSH) and reactive oxygen species (ROS) in pyrogallol-induced HeLa cell death. We measured the changes of ROS levels, GSH levels, sub-G1 cells, annexin V/PI staining cells and mitochondria membrane potential (ΔΨ m ) in HeLa cells treated with pyrogallol and/or ROS scavenger. The intracellular ROS levels were decreased or increased depending on the concentration of pyrogallol. The level of O 2
Introduction
Reactive oxygen species (ROS) include hydrogen peroxide (H 2 O 2 ), superoxide anion (O 2
•-) and hydroxyl radical ( • OH). They have recently been implicated in the regulation of many important cellular events, including transcription factor activation, gene expression, differentiation and proliferation (1) (2) (3) . ROS are formed as by-products of mitochondrial respiration or oxidases including nicotine adenine diphosphate (NADPH) oxidase, xanthine oxidase (XO) and certain arachidonic acid oxygenases (4) . A change in the redox state of the tissue implies a change in ROS generation or metabolism. Principal metabolic pathways include superoxide dismutase (SOD), which is expressed as extracellular, intracellular, and mitochondrial isoforms. They metabolize O 2
•-to H 2 O 2 . Further metabolism by peroxidases that include catalase and glutathione peroxidase yields O 2 and H 2 O (5). Cells possess antioxidant systems to control the redox state, which is important for their survival. Excessive production of ROS gives rise to the activation of events which lead to death and survival in many different types of cells (6) (7) (8) (9) . The accurate mechanisms involved in cell death induced by ROS are not fully understood and the protective effect mediated by some antioxidants remains controversial.
Pyrogallol is a polyphenol and is known to be an O 2
•-generator (10, 11) . This compound is often used to investigate the role of O 2 •-in biological systems. For example, pyrogallol was shown to induce the O 2
•--mediated death of several types of cell such as mouse myocytes (12) , and mesangial (13) , human lymphoma (10) , and human glioma cells (14) . Recently, we showed that pyrogallol inhibited the growth of HeLa cells with an IC 50 of about 45 μM (15) . Pyrogallol efficiently induced apoptosis, as evidenced by the flow cytometric detection of sub-G1 DNA content, annexin V binding assay and DAPI staining. This apoptotic process was accompanied by the loss of mitochondrial membrane potential (ΔΨ m ), Bcl-2 down-regulation, the activation of caspase-3 and PARP degradation (15) .
In the present study, we evaluated an involvement of GSH and ROS such as H 2 O 2 and O 2
•-in pyrogallol-induced HeLa cell death and investigated whether ROS scavengers rescue cells from pyrogallol-induced HeLa cell death.
Materials and methods
Cell culture. Human cervical adenocarcinoma HeLa cells were maintained in humidified incubator containing 5% CO 2 at 37˚C. HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Gibco BRL, Grand Island, NY). Cells were routinely grown in 100-mm plastic tissue culture dishes (Nunc, Roskilde, Denmark) and harvested with a solution of trypsin-EDTA when they were in logarithmic phase of growth. Cells were maintained in these culture conditions for all experiments.
Reagents. Pyrogallol purchased from Sigma-Aldrich Chemical Company (St. Louis, MO) was dissolved in H 2 O at 1x10 -1 M as a stock solution. The cell permeable O 2
•-scavengers, 4-hydroxy-TEMPO (4-hydroxyl-2,2,6,6-tetramethylpierydine-1-oxyl) (Tempol) and Tiron (4,5-dihydroxyl-1,3-benzededisulfonic acid), Trimetazidine [1-(2,3,4-trimethoxibenzyl)-piperazine] and NAC (N-acetylcysteine) were obtained from Sigma and dissolved in designated solution buffer at 1x10 -1 M as a stock solution. SOD and catalase were obtained from Sigma and dissolved in 50 mM potassium phosphate buffer at 4733 U/ml. All stock solutions were wrapped in foil and kept at 4 or -20˚C.
Sub-G1 analysis. Sub-G1 distributions were determined by staining DNA with propidium iodide (PI) (Sigma) as described previously (16, 17) . PI is a fluorescent biomolecule that can be used to stain DNA. Briefly, 1x10 6 cells were incubated with the designated drug doses for 72 h. The cells were then washed in phosphate-buffered saline (PBS) and fixed in 70% ethanol. The cells were again washed with PBS and then incubated with PI (10 μg/ml) with simultaneous treatment of RNase at 37˚C for 30 min. The percentages of cells containing the sub-G1 DNA were measured with a FACStar flow cytometer (Becton Dickinson, San Jose, CA) and analyzed using Lysis II and CellFit software (Becton Dickinson).
Annexin V/PI staining. Apoptosis was determined by staining cells with annexin V-fluorescein isothiocyanate (FITC) (Ex/Em 488/519 nm) and PI (Ex/Em 488/617 nm) labeling, as annexin V can identify the externalization of phosphatidylserine during the progression of apoptosis, and therefore detect cells early in apoptosis. PI can also be used to differentiate necrotic, apoptotic and normal cells. This agent is membrane-impermeant and is generally excluded from viable cells. Briefly, 1x10
6 cells were incubated with the designated drug doses for 72 h. Cells were washed twice with cold PBS and then re-suspended in 500 μl of binding buffer [10 mM HEPES/NaOH (pH 7.4), 140 mM NaCl, 2.5 mM CaCl 2 ] at a concentration of 1x10 6 cells/ml. Annexin V-FITC (5 μl) (PharMingen, San Diego, CA) and PI (1 μg/ml) were then added to these cells, which were analyzed with a FACStar flow cytometer. Viable cells were negative for both PI and annexin V; apoptotic cells were positive for annexin V and negative for PI, whereas late apoptotic dead cells displayed both high annexin V and PI labeling. Non-viable cells, which underwent necrosis, were positive for PI and negative for annexin V.
Measurement of mitochondrial membrane potential (ΔΨ m ).
The mitochondrial membrane was monitored using the fluorescent dye Rhodamine 123, a cell-permeable cationic dye, which preferentially enters mitochondria due to a highly negative mitochondrial membrane potential (ΔΨ m ). Depolarization of mitochondrial membrane potential (ΔΨ m ) results in the loss of Rhodamine 123 from the mitochondria and a decrease in intracellular fluorescence (Ex/Em 485/535 nm). Briefly, 1x10 6 cells were incubated with the designated doses of drugs for 72 h. The cells were washed twice with PBS and incubated with Rhodamine 123 (0.1 μg/ml; Sigma) at 37˚C for 30 min. PI (1 μg/ml) was subsequently added, and Rhodamine 123 and PI staining intensity were determined by flow cytometry.
Detection of intracellular ROS and O 2
•-concentration. •-) among ROS. DHE is cell permeable and reacts with superoxide anion to form ethidium, which in turn intercalates in the deoxyribonucleic acid, thereby exhibiting a red fluorescence (Ex/Em 515/595 nm). Briefly, cells were incubated with the designated doses of pyrogallol combined with or without ROS scavengers for 72 h. Cells were then washed in PBS and incubated with 20 μM H 2 DCFDA or 5 μM DHE at 37˚C for 30 min according to the manufacturer's instructions. DCF fluorescence and red fluorescence were detected by a FACStar flow cytometer. In particular, DCF fluorescence intensity was significantly increased in H 2 O 2 -treated HeLa cells (data not shown). For each sample, 5,000 or 10,000 events were collected. ROS levels were expressed as mean fluorescence intensity (MFI), which was calculated by CellQuest software.
Detection of intracellular glutathione (GSH)
. Cellular GSH levels were analyzed using 5-chloromethylfluorescein diacetate (CMFDA, Molecular Probes). CMFDA is a useful membrane-permeable dye (Ex/Em 492/517 nm) for determining levels of intracellular glutathione as previously described (18) . Briefly, cells were incubated with the designated doses of pyrogallol with or without ROS scavengers for 72 h. Cells were then washed in PBS and incubated with 5 μM CMFDA at 37˚C for 30 min according to the manufacturer's instructions. Cytoplasmic esterases convert nonfluorescent CMFDA to fluorescent 5-chloromethylfluorescein, which can then react with the glutathione (Ex/Em 522/595 nm). PI (1 μg/ml) was subsequently added, and CMF fluorescence and PI staining intensity were determined by a FACStar flow cytometer and calculated by CellQuest software. For each sample, 5,000 or 10,000 events were collected.
Measurement of cellular superoxide dismutase activity. The level of cellular SOD enzyme activity was measured using the SOD Assay Kit-WST (Fluka Co, Milwaukee, WI), which allows convenient SOD assaying by utilizing a highly water- were incubated with the designated doses of pyrogallol for 72 h, washed with PBS and suspended in five volumes of lysis buffer [20 mM HEPES (pH 7.9), 20% Glycerol, 200 mM KCl, 0.5 mM EDTA, 0.5 % NP40, 0.5 mM DTT, 1% protease inhibitor cocktail (Sigma)]. The lysates were then collected and stored at -20˚C until further use. Supernatant protein concentration was determined by the Bradford method. Supernatant samples containing 30 μg of total protein were used for the determination of SOD enzyme activity according to the manufacturer's instructions. After 10 min incubation, the WST-1 formazan was measured at 450 nM using a microplate reader (Spectra Max 340, Molecular Devices Co., Sunnyvale, CA). The value for the experimental group was converted to the percentage of control group.
Statistical analysis.
Results represent the mean of at least 2 or 3 independent experiments; the bars in the figures indicate standard deviation. Microsoft Excel or Instat software (GraphPad Prism4, San Diego, CA) was used to analyze the data. Student's t-test or one-way analysis of variance (ANOVA) with post hoc analysis using Tukey's multiple comparison test were used for parametric data. Statistical significance was defined as p<0.05.
Results

Effect of pyrogallol on ROS, SOD activity and GSH production in HeLa cells.
We investigated the levels of ROS in pyrogallol-treated HeLa cells. To assess the production of intracellular ROS in pyrogallol-treated HeLa cells, we used H 2 DCFDA fluorescence dye. We first screened HeLa cells with a broad range concentrations of pyrogallol and various incubation periods and chose the optimal range of pyrogallol doses (20- generator (10, 11) . Therefore, we investigated the change of intracellular O 2
•-levels in pyrogallol-treated HeLa cells. Red fluorescence derived from DHE, indicating the accumulation of intracellular O 2
•-, in pyrogallol-treated HeLa cells, was increased in a dose-dependent manner (Fig. 1B and D) . We recently demonstrated that 60 μM pyrogallol inhibited the growth of HeLa cells ~85% using MTT assay and induced apoptosis in ~30% (15) . In this experiment, we used a concentration of 60 μM pyrogallol. This concentration was considered to be a suitable dose to differentiate apoptosis levels in the presence of pyrogallol versus apoptosis in the presence of pyrogallol and ROS scavengers including SOD and catalase. When treated with 60 μM pyrogallol for the short time periods (30-180 min), HeLa cells showed a decrease in general ROS levels and an increase in O 2
•-levels (data not shown). In addition, SOD activity was significantly decreased in 60 μM pyrogallol-treated HeLa cells (Fig. 1E) .
Cellular GSH has been shown to be crucial for the regulation of cell proliferation, cell cycle progression and apoptosis (19, 20) . We therefore analyzed the GSH levels of HeLa cells by using CMF fluorescence. The M1 population of HeLa cells showed lower levels of intracellular GSH content ( Fig. 2A) . Pyrogallol significantly elevated the percentages of cells residing in the M1 population in a dosedependent manner at 72 h ( Fig. 2A and B) , which indicated the depletion of the intracellular GSH content in HeLa cells following treatment with pyrogallol. Next, to evaluate whether the M1 population of cells in the negative CMFfluorescent region were dead, we performed additional staining of cells with PI in order to verify the disruption of the plasma membrane. As shown in Fig. 2C and D, many CMF-negative-fluorescent cells showed PI-positive staining, which indicated that cells showing lower levels of GSH content were dead. The proportion of CMF-depleted dead cells increased in the presence of pyrogallol in a dosedependent manner. In addition, when treated with 60 μM pyrogallol for the short time periods (30-180 min), HeLa cells showed a decrease in GSH levels at these times (data not shown).
Effects of ROS scavengers on ROS production, GSH depletion and apoptosis in pyrogallol-treated HeLa cells.
To determine whether ROS production and GSH depletion in pyrogalloltreated HeLa cells were changed by ROS scavengers, cellpermeable ROS scavengers, Tempol and Tiron (11), and a well-known antioxidant, NAC, were co-incubated with pyrogallol-treated HeLa cells for 72 h. An anti-ischemic and metabolic agent, Trimetazidine was also used as an indirect antioxidant (21, 22) . To measure the accurate intracellular fluorescence level of ROS, we used only the cells residing in the R2 region. These cells are considered to have intact plasma membrane ( Fig. 3A and B) . The scavengers, with the exception of NAC, did not significantly change the intracellular ROS levels in 60 μM pyrogallol-treated cells (Fig. 3A and D) . NAC increased the level of ROS in pyrogallol-treated cells. None of the scavengers reduced the O 2
•-levels in pyrogalloltreated cells (Fig. 3B and E) . In contrast, the treatment with Tiron increased the intracellular O 2
•-levels. The scavengers, excepting NAC, did not also inhibit depletion of the GSH content in pyrogallol-treated HeLa cells (Fig. 3C and F) . Tiron showed instead the significant enhancement of GSH depletion ( Fig. 3C and F) . Treatment with NAC inhibited the GSH depletion in pyrogallol-treated cells at 72 h (Fig. 3C and F) and also recovered the reduced GSH levels in these cells at the early time points (30-180 min) (data not shown). Next, we evaluated whether the M1 population of cells in the negative CMF-fluorescent region were alive or dead. As shown in Fig. 4 , the negative CMF fluorescent cells showed, on the whole, PI-positive staining, indicating that the cells showing GSH depletion were generally dead. The proportions of CMF-negative and PI-positive cells were significantly increased in Tiron-treated cells, indicating that Tiron exaggerated the disruption of the plasma membrane. Conversely, treatments with NAC reduced the proportions of CMFnegative and PI-positive cells. All of the ROS scavengers used in this experiment did not significantly alter the intracellular ROS and GSH levels in HeLa control cells (data not shown).
Next, we attempted to examine whether these scavengers inhibited pyrogallol-induced HeLa cell death. The scavengers, excepting NAC, did not prevent pyrogallol-induced apoptosis in the cells (Fig. 5) . NAC significantly inhibited apoptosis compared with pyrogallol-treated cells (approximately 50 vs. 83%) in view of sub-G1 cells, annexin V staining cells and the loss of mitochondrial membrane potential (ΔΨ m ). In contrast, Tiron intensified apoptosis levels in pyrogallol- treated HeLa cells as evidenced by annexin V staining cells and the loss of mitochondrial membrane potential (ΔΨ m ) ( Fig. 5E and F) . Additionally, the high concentrations (1 or 2.5 mM) of ROS scavengers, with the exception of NAC, were not used due to their toxicity in HeLa control cells, but the higher doses of NAC also strongly inhibited the death of HeLa cells induced by pyrogallol (data not shown).
Effects of SOD and catalase on ROS production, GSH depletion and apoptosis in pyrogallol-treated HeLa cells.
Next, to determine whether ROS production and GSH depletion in pyrogallol-treated HeLa cells were changed by exogenous SOD and catalase, HeLa cells were treated with pyrogallol in the presence or absence of SOD (30 U/ml) or/and catalase (30 U/ml) for 72 h. As shown in Fig. 6A , SOD increased the levels of ROS in pyrogallol-treated HeLa cells and catalase also increased the intracellular ROS. In regard to the O 2
•-levels in relation to SOD and catalase, SOD did not decrease the O 2
•-levels but catalase significantly decreased the O 2
•-levels in pyrogallol-treated cells (Fig. 6B) . When we assessed the levels of intracellular GSH, SOD and catalase significantly inhibited the depletion of GSH content in HeLa cells treated with pyrogallol (Fig. 6C ). Catalase showed a stronger effect on recovery of GSH depletion than SOD. However, treatment with catalase did not recover the reduced GSH levels in pyrogallol-treated cells at the early time points (30-180 min) (data not shown). No synergistic or additive effects of SOD and catalase on the inhibition of GSH depletion were detected.
Next, we examined whether SOD and catalase could prevent pyrogallol-induced HeLa cell death. SOD and catalase significantly decreased apoptosis in HeLa cells treated with pyrogallol (Fig. 7) . Catalase strongly decreased the sub-G1 cells and the annexin V-positive stained cells in pyrogallol-treated HeLa cells by approximately 80% (Fig. 7A and D, and Fig. 7B and E, respectively) . In addition, catalase showed a stronger effect on reducing the loss of mitochondrial transmembrane potential (ΔΨ m ) in pyrogallol-treated HeLa cells than did SOD (Fig. 7C and F ). There were no synergistic or additive effects of SOD and catalase on the reduction of apoptosis. In regard to CMF-negative and PI-positive cells, SOD reduced the proportion of CMF-negative and PIpositive cells induced by pyrogallol, and catalase was stronger in reducing the proportion than was SOD (Fig. 8A  and B) . Interestingly, the negative CMF-fluorescent cells in pyrogallol and catalase-treated cells showed a small number of PI-positive cells (Fig. 8A and C) , indicating that catalase strongly maintained the integrity of the cell membrane in pyrogallol-treated cells.
Discussion
In this study, we focused on the involvement of ROS such as H 2 O 2 and O 2
•-, and GSH in pyrogallol-induced HeLa cell death. Our data showed that the intracellular ROS levels (DCF fluorescence intensity) were increased in 20 μM pyrogallol-treated cells. However, the general ROS levels were decreased in HeLa cells treated with higher doses of pyrogallol (40-200 μM). It is possible that the leakage of DCF dye occurred due to cell death after treatment with the higher doses of pyrogallol. Pyrogallol is often used to investigate the role of O 2 •-in biological systems. As we expected, the intracellular O 2
•-levels were significantly increased in a dosedependent manner. One interpretation of these increases is that pyrogallol strongly inhibited SOD activity (Fig. 1E) , resulting in an accumulation in O 2
•-level due to a slow conversion from O 2
•-to H 2 O 2 . It has been suggested that the apoptotic effects of pyrogallol are correlated with the changes of intracellular O 2
•-level in pheochromocytoma PC12 cells (11) , human neuroblastoma SH-SY5Y cells (23) and juxtaglomerular As4.1 cells (24) . Therefore, we attempted to determine whether ROS scavengers prevent pyrogallol-induced cell death through the reduction of intracellular O 2
•-levels. In contrast to our expectations, all the scavengers used in this experiment did not significantly reduce the level of O 2
•-in HeLa cells treated with 60 μM pyrogallol. Tiron significantly increased the level of O 2
•-. The weak effects of these scavengers, especially Tempol and Tiron as O 2
•-scavengers, may be due to the lower doses used or/and the long incubation periods, since Yamada et al showed that the effects of Tempol and Tiron on reduction in O 2
•-levels occurred at 3 h and at more than 1 mM concentration of those in pyrogallol-treated PC12 cells (11) . In addition, these scavengers with the exception of NAC could not reduce apoptosis in pyrogallol-treated cells. In particular, Tiron increased apoptosis levels with the increase of O 2
•-production. As Tiron can also generate superoxide as a catechol under different conditions, this may enhance the toxicity of pyrogallol in these experimental conditions. Conversely, NAC significantly decreased apoptosis levels without the reduction of the intracellular O 2
•-levels in •-levels in pyrogallol-treated cells. These results suggest that the changes of intracellular O 2
•-level are at least partially correlated to apoptosis in pyrogallol-treated HeLa cells. In addition, the exact mechanisms of cell death through intracellular ROS in pyrogallol-treated HeLa cells still need to be defined further.
With regard to intracellular GSH, a main non-protein antioxidant in the cell, it is able to clear away the superoxide anion free radical and provide electrons for enzymes such as glutathione peroxidase, which reduce H 2 O 2 to H 2 O. It has been reported that intracellular GSH content has a decisive effect on anticancer drug-induced apoptosis, indicating that apoptotic effects are inversely comparative to GSH content (25, 26) . We have also demonstrated that pyrogallol induces apoptosis in As4.1 juxtaglomerular cells through the depletion of intracellular GSH content (27) . Likewise, our current result clearly indicated the depletion of intracellular GSH content by pyrogallol in HeLa cells. These results support that the change of intracellular GSH levels is tightly correlated with pyrogallol-induced cell death. In fact, NAC showing significantly the recovery of GSH depletion was found to decrease PI-positive cells in pyrogallol-treated HeLa cells. In addition, we observed that the level of GSH content in pyrogallol-treated HeLa cells was decreased about 50% at the early time point of 30 min. However, at this time, the O 2
•-level in these cells was not strongly increased. These results suggested that pyrogallol plays a role as a GSH depletor itself, as well as an O 2
•-generator. Treatment with catalase showed a stronger effect on the recovery of GSH depletion induced by pyrogallol than SOD. This result is consistent with the notion that the redox system can maintain normal intracellular GSH levels by regulating catalase and peroxidase activity rather than SOD. Such a proportion of GSH content regulated by SOD and catalase in pyrogallol-treated HeLa cells could also be applicable to apoptosis levels such as annexin V-positive staining and the loss of mitochondrial transmembrane potential (ΔΨ m ). In fact, catalase had a strong anti-apoptotic effect compared with SOD. Treatment with catalase also significantly maintained the integrity of the plasma membrane in CMF-negative cells. We observed no synergistic or additive effects of SOD and catalase on ROS levels, GSH content and apoptosis parameters. It is possible that catalase works downstream of SOD and the level of intracellular GSH regulated by catalase is a critical factor in triggering apoptosis.
In summary, we demonstrated that pyrogallol potently increased intracellular ROS, especially O 2
•-and decreased GSH content in HeLa cells, and NAC, SOD and catalase significantly rescued cells from pyrogallol-induced apoptosis accompanied by the recovery of GSH depletion (Fig. 9) .
